David M. Jackman, MD
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Study of Hsp90 Inhibitor, STA-9090 for Relapsed or Refractory Small Cell Lung Cancer (NCT01173523) | David M. Jackman, MD | 2010-07-28 |
| Erlotinib Therapy and Subsequent Development of Mechanisms of Secondary Resistance in Patients With NSCLC (NCT00997334) | David M. Jackman, MD | 2010-02-01 |
| High Dose Gefitinib for the Treatment of Carcinomatous Meningitis in Adult Patients With Non-Small Cell Lung Cancer and Known or Suspected EGFR Mutations (NCT00372515) | David M. Jackman, MD | 2006-06-01 |
Track David M. Jackman, MD automatically
Every clearance here is in the API, with alerts when new ones post.